Table 2. Disease criteria and standardized part-worth utility values (β) for disease criteria levels by country.
Disease criteria1 and corresponding levels | Canada | US | t 4 | ||
MUV 2 | SD 3 | MUV 2 | SD 3 | ||
Duration of illness in humans | |||||
No illness observed or only a few days of illness | −47.58 | 22.40 | −46.58 | 31.05 | 0.72∧ |
Short-term illness (weeks) | −26.00 | 23.78 | −22.08 | 16.16 | 3.78*** ∧ |
Medium-term illness (months) | 6.26 | 21.34 | 3.24 | 23.55 | 2.64** ∧ |
Chronic illness (years) or illness with permanent deficits | 67.32 | 30.94 | 65.42 | 30.09 | 1.23 |
Transmission potential from animals to humans | |||||
No transmission from animals to humans | −38.81 | 18.86 | −41.89 | 17.39 | 3.33** ∧ |
Low transmission from animals to humans | −28.33 | 18.40 | −33.07 | 17.43 | 5.19*** |
Moderate transmission from animals to humans | 5.23 | 17.15 | 13.03 | 16.83 | 9.00*** |
High | 61.91 | 21.12 | 61.93 | 21.09 | 0.02 |
Disease trend in Canada/US in the last five years in animals | |||||
Decline over the last five years | −47.50 | 21.98 | −48.38 | 21.66 | 0.80 |
Stable over the last five years | −24.50 | 18.50 | −26.24 | 19.01 | 1.82 |
Increase over the last five years | 25.03 | 18.23 | 28.13 | 17.74 | 3.38** |
New emerging disease, rapid increase over the last five years | 46.97 | 22.54 | 46.49 | 24.71 | 0.40∧ |
Economic burden in humans | |||||
No cost to the health care system and individuals | −35.66 | 26.38 | −34.54 | 24.26 | 0.86∧ |
Low cost ($100 per sick individual) | −14.78 | 22.27 | −22.16 | 18.03 | 7.14*** ∧ |
Moderate cost ($1,000 per sick individual) | 6.50 | 16.63 | 8.61 | 16.44 | 2.50* |
High cost ($10,000 per sick individual) | 43.94 | 36.21 | 48.10 | 31.32 | 2.41* ∧ |
Transmission potential from humans to animals | |||||
No transmission from humans to animals | −26.88 | 17.37 | −27.19 | 21.58 | 0.31∧ |
Low transmission from humans to animals | −25.98 | 18.96 | −27.03 | 19.44 | 1.07 |
Moderate transmission from humans to animals | 6.74 | 15.47 | 13.44 | 15.48 | 8.49*** |
High transmission from humans to animals | 46.13 | 26.65 | 40.79 | 22.95 | 4.21*** ∧ |
Duration of illness in animals | |||||
No illness observed or only a few days of illness | −28.32 | 19.05 | −33.47 | 18.99 | 5.31*** |
Short-term illness (weeks) | −9.97 | 20.26 | −10.85 | 17.58 | 0.91∧ |
Medium-term illness (months) | 1.21 | 18.71 | 6.68 | 17.37 | 5.93*** ∧ |
Chronic illness (years) or illness with permanent deficits | 37.08 | 24.28 | 37.63 | 22.53 | 0.47∧ |
Transmission potential between animals | |||||
No transmission between animals | −27.27 | 21.02 | −23.24 | 18.21 | 4.01*** ∧ |
Low transmission between animals | −13.53 | 15.78 | −18.35 | 13.60 | 6.42*** ∧ |
Moderate transmission between animals | 4.76 | 15.33 | 3.52 | 18.29 | 1.45∧ |
High transmission between animals | 36.03 | 18.62 | 38.08 | 18.44 | 2.17* |
Presented in order of importance to Canadian participants.
Mean part-worth utility values (β) across respondents.
Standard deviation of mean part-worth utility values (β) across respondents.
t-statistic; d.f. = 1,537.
p<0.05,
p<0.01,
p<0.001.
Adjusted for unequal variance using the Welch t-test; Satterthwaite’s d.f. = 1,282.61 to 1531.22.